The history of the erectile dysfunction drug presents a complex picture for investors. While the initial launch generated significant returns, the end of its exclusive rights opened the avenue to generic competitors, https://emilyywaw221200.bloggactivo.com/40848136/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet